BioLineRx inks stock sale agreement with institutional investor

|About: BioLineRx Ltd. (BLRX)|By:, SA News Editor

BioLineRx (BLRX -1.4%) signs a 36-month purchase agreement for the sale, from time to time, of up to $20M of its ADSs to Lincoln Park Capital Fund LLC. The timing and amount of the sales are at the sole discretion of BLRX and the agreement can be terminated at any time without cost or penalty.

Under the terms of the agreement, BLRX will maintain an effective registration statement with the SEC for all shares sold.